Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Miosis refers to the excessive constriction of the pupil, resulting in a pupil diameter of less than 2 mm. It is a physiological response to bright light or near focus, but can also be caused by various pathological conditions, including neurological disorders, drug intoxication, and aging. The process is controlled by the sphincter pupillae muscle and the parasympathetic nervous system. Persistent or inappropriate miosis can be a sign of underlying health issues and is assessed as part of neurological examinations.
Pupillary constriction is primarily mediated by the contraction of the sphincter pupillae muscle, controlled by the parasympathetic nervous system. Drugs can induce miosis through various mechanisms, including activation of muscarinic receptors or inhibition of acetylcholinesterase.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pupil (Miosis).